Related Experiment Video
Updated: Jun 17, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10
Zhiqiang Qin1, Patricia Kearney, Karlie Plaisance
1Department of Medicine, Hollings Cancer Center, Medical University of South Carolina,Charleston, South Carolina, USA.
Abstract:
Macrophages are an important source of inflammatory cytokines generated during the innate immune response,but in the microenvironment of certain tumors,macrophages promote tumor progression through their preferential secretion of cytokines that support tumor cell growth and suppress antitumoral immune responses. KSHV is the causative agent of KS and lymphomas preferentially arising in immuno compromised patients, and specific cytokines, including IL-6 and IL-10, have been implicated in KSHV-associated cancer pathogenesis. However, the contribution of KSHV-infected macrophages to the cytokine milieu within KSHV-related tumors is unclear. We found that individual KSHV-encoded miRNA induce IL-6 and IL-10 secretion independently and additively by murine macrophages and human myelomonocytic cells. Bioinformatics analysis identified KSHV miRNA binding sites formiR-K12-3 and miR-K12-7 within the 3'UTR of the basic region/leucine zipper motif transcription factor C/EBPbeta, a known regulator of IL-6 and IL-10 transcriptional activation.Subsequent immunoblot analyses revealed that miR-K12-3 and miR-K12-7 preferentially reduce expression of C/EBPbeta p20 (LIP), an isoform of C/EBPbeta known to function as a negative transcription regulator. In addition,RNA interference specifically targeting LIP induced basal secretion of IL-6 and IL-10 by macrophages.Taken together, these data support a role for KSHV miRNA in the programming of macrophage cytokine responses in favor of KSHV-related tumor progression.
Insights
Kaposi sarcoma-associated herpesvirus (KSHV) encoded microRNAs reprogram macrophages to secrete tumor-promoting cytokines like IL-6 and IL-10. This reprogramming involves targeting the C/EBPbeta transcription factor, driving KSHV-driven cancer progression.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Macrophages are key immune cells that can either fight or promote tumors.
- In KSHV-associated cancers, macrophages may contribute to tumor growth by secreting specific cytokines.
- The precise role of KSHV-infected macrophages in shaping the tumor microenvironment's cytokine profile remains unclear.
Purpose of the Study:
- To investigate how KSHV-encoded microRNAs influence macrophage cytokine secretion.
- To determine the molecular mechanisms by which KSHV miRNAs affect cytokine production in macrophages.
- To elucidate the role of KSHV-driven macrophage reprogramming in KSHV-associated tumorigenesis.
Main Methods:
- Utilized murine macrophages and human myelomonocytic cells to study KSHV miRNA effects.
- Employed bioinformatics to identify miRNA binding sites on target genes.
- Performed immunoblot analyses to assess protein expression changes.
- Used RNA interference to validate the role of specific protein isoforms.
Main Results:
- KSHV microRNAs (miRNAs) were found to induce secretion of IL-6 and IL-10 in macrophages.
- Bioinformatics and immunoblotting revealed KSHV miRNAs target C/EBPbeta transcription factor, specifically reducing the inhibitory isoform LIP.
- Targeting LIP directly led to increased IL-6 and IL-10 secretion by macrophages.
Conclusions:
- KSHV miRNAs play a significant role in programming macrophage cytokine responses.
- This reprogramming favors the secretion of pro-tumorigenic cytokines (IL-6, IL-10) by macrophages.
- These findings highlight a mechanism by which KSHV promotes cancer progression through macrophage manipulation.
More Related Videos
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Mechanisms of Retrovirus-induced Cancers

